Statistics for Oral administration of a 2-aminopyrimidine robenidine analogue (NCL195) significantly reduces Staphylococcus aureus infection and reduces Escherichia coli infection in combination with sub-inhibitory colistin concentrations in a bioluminescent mouse model

Total visits

views
Oral administration of a 2-aminopyrimidine robenidine analogue (NCL195) significantly reduces Staphylococcus aureus infection and reduces Escherichia coli infection in combination with sub-inhibitory colistin concentrations in a bioluminescent mouse model 17

Total visits per month

views
February 2025 1
March 2025 2
April 2025 3
May 2025 4
June 2025 0
July 2025 4
August 2025 1

File Visits

views
hdl_139651.pdf 3